• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年颅内肿瘤的大剂量类固醇疗法。

High-dose steroid therapy of intracranial tumour in the elderly.

作者信息

Graham K, Caird F I

出版信息

Age Ageing. 1978 Aug;7(3):146-50. doi: 10.1093/ageing/7.3.146.

DOI:10.1093/ageing/7.3.146
PMID:707243
Abstract

Twenty elderly patients with intracranial tumour were treated with high-dose steroids (beta- or dexamethasone 12--16 mg per day). Six of eight patients with primary intracranial malignancies and four of six with metastatic tumours showed a definite response of conscious level and/or neurological deficit. One of two patients with lymphoma responded but neither of two with meningioma. Six patients were able to return home. Two patients suffered serious, and three minor, side-effects attributable to steroid therapy, but this treatment has a definite place in the management of intracranial tumour in old age.

摘要

20例老年颅内肿瘤患者接受了大剂量类固醇治疗(β-米松或地塞米松,每日12 - 16毫克)。8例原发性颅内恶性肿瘤患者中有6例,6例转移性肿瘤患者中有4例在意识水平和/或神经功能缺损方面有明确改善。2例淋巴瘤患者中有1例有反应,但2例脑膜瘤患者均无反应。6例患者能够回家。2例患者出现了严重的类固醇治疗副作用,3例出现轻微副作用,但这种治疗在老年颅内肿瘤的治疗中确有一席之地。

相似文献

1
High-dose steroid therapy of intracranial tumour in the elderly.老年颅内肿瘤的大剂量类固醇疗法。
Age Ageing. 1978 Aug;7(3):146-50. doi: 10.1093/ageing/7.3.146.
2
Factors affecting platinum concentrations in human surgical tumour specimens after cisplatin.顺铂治疗后影响人类手术肿瘤标本中铂浓度的因素。
Br J Cancer. 1995 Mar;71(3):598-604. doi: 10.1038/bjc.1995.116.
3
[Clinical control trial of methylprednisolone and dexamethasone in treatment of intracranial tumor edema].甲泼尼龙与地塞米松治疗颅内肿瘤水肿的临床对照试验
Sichuan Da Xue Xue Bao Yi Xue Ban. 2003 Apr;34(2):327-9.
4
Steroid-induced regression of primary malignant lymphoma of the brain.
Surg Neurol. 1986 Sep;26(3):291-6. doi: 10.1016/0090-3019(86)90165-5.
5
Clinical evaluation of the action of dexamethasone.
Anaesth Resusc Intensive Ther. 1975 Apr-Jun;3(2):157-63.
6
Effects of dexamethasone on peritumoural oedematous brain: a DT-MRI study.地塞米松对肿瘤周围脑水肿的影响:一项扩散张量磁共振成像研究。
J Neurol Neurosurg Psychiatry. 2004 Nov;75(11):1632-5. doi: 10.1136/jnnp.2003.028647.
7
[Therapeutic management of central nervous system lymphomas in a single hematological institute].[单一血液学机构中中枢神经系统淋巴瘤的治疗管理]
Orv Hetil. 2009 Oct 18;150(42):1937-44. doi: 10.1556/OH.2009.28703.
8
Quantitative assessment of intracranial tumor response to dexamethasone using diffusion, perfusion and permeability magnetic resonance imaging.使用扩散、灌注和渗透性磁共振成像对颅内肿瘤对地塞米松的反应进行定量评估。
Magn Reson Imaging. 2007 Apr;25(3):303-10. doi: 10.1016/j.mri.2006.09.002. Epub 2006 Nov 13.
9
Dose-effect relationship of dexamethasone on Karnofsky performance in metastatic brain tumors: a randomized study of doses of 4, 8, and 16 mg per day.
Neurology. 1994 Apr;44(4):675-80. doi: 10.1212/wnl.44.4.675.
10
Dexamethasone treatment in patients with brain metastases and primary brain tumors: do the benefits outweigh the side-effects?地塞米松治疗脑转移瘤和原发性脑肿瘤患者:益处是否大于副作用?
Support Care Cancer. 2002 May;10(4):322-8. doi: 10.1007/s00520-001-0333-0. Epub 2002 Feb 9.

引用本文的文献

1
Evidence-based dexamethasone dosing in malignant brain tumors: what do we really know?基于证据的恶性脑肿瘤地塞米松剂量:我们到底知道多少?
J Neurooncol. 2019 Sep;144(2):249-264. doi: 10.1007/s11060-019-03238-4. Epub 2019 Jul 25.
2
Treatment of nausea and vomiting in terminally ill cancer patients.晚期癌症患者恶心呕吐的治疗
Drugs. 2008;68(18):2575-90. doi: 10.2165/0003495-200868180-00004.
3
Peptic ulcer disease and other complications in patients receiving dexamethasone palliation for brain metastasis.接受地塞米松姑息治疗脑转移患者的消化性溃疡疾病及其他并发症。
West J Med. 1982 Nov;137(5):375-8.